7.6K
Downloads
31
Episodes
From business publication BioProcess International comes The BioProcess Insider Expression Platform (BIEP). Editor Dan Stanton takes a look beyond the nuts and bolts of the biomanufacturing industry and speaks to some of the pioneers and thought leaders turning production on its head. www.bioprocessinsider.com
Episodes
Wednesday Apr 21, 2021
Wednesday Apr 21, 2021
The cell and gene therapy sector is on the cusp of flourishing in the vast pharma landscape. Money is flowing in, manufacturing challenges are being overcome, people are actually being treated and cured. Even COVID-19 may be seen as a driving force for the burgeoning sector. But what does the future hold? Ernst & Young’s Adlai Goldberg describes the steps industry must take to advance the advanced therapy space and how it must move to balance the individualized autologous approach with more sustainable allogeneic products.
Keep up with BioProcess Insider on our website.
Follow us on LinkedIn and Twitter:
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.